{"title":"PLGA-The Smart Biocompatible Polimer: Kinetic Degradation Studies and Active Principle Release.","authors":"Maria-Viorica Ciocîlteu, Rău Gabriela, Manuel Ovidiu Amzoiu, Denisa Constantina Amzoiu, Cătălina Gabriela Pisoschi, Beatrice Anne-Marie Poenariu","doi":"10.12865/CHSJ.49.03.15","DOIUrl":"10.12865/CHSJ.49.03.15","url":null,"abstract":"<p><p>The aim of our research was the development of prolonged delivery systems for therapeutic agents with various properties (prevention and treatment of bone diseases, anti-neoplastic, anti-inflammatory, antioxidant) that would ensure sustained therapeutic levels of the active principle, above the minimum inhibitory concentration, without reaching toxic levels over a long period of time as alternatives to conventional routes of administration. PLGA (poly lactic-co-glycolic acid), a biodegradable and biocompatible synthetic polymer, FDA approved, with a 65:35 lactic acid (LA): glycolic acid (GA) copolymer ratio, was chosen as delivery system. Our studies have shown that in PBS it undergoes two simultaneous degradation processes, hydrolysis and autohydrolysis, degrading completely in about 40 days. The release of the active principle is determined by the diffusion from inside the polymer matrix to the outside, which occurs simultaneously with the erosion of the polymer, during 35 days.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 3","pages":"416-422"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10832882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139682156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Acute Toxicity by Salvia Officinalis: A Rare Cause of Intestinal Sub-Occlusion.","authors":"Alessandro Rapino, Giovanna Ceccuzzi, Benedetta Perna, Roberto DE Giorgio, Matteo Guarino","doi":"10.12865/CHSJ.49.03.17","DOIUrl":"10.12865/CHSJ.49.03.17","url":null,"abstract":"<p><p>Salvia officinalis is a perennial plant commonly used in culinary and medical preparations. Its large intake is usually related to psychiatric disorders (such as pica) and might induce different symptoms (e.g. vomiting, nausea, diarrhoea, salivation, arterial hypertension, tachycardia, vertigo, flushes, cyanosis and convulsions) likely ascribable to pro-cholinergic effects of various constituents. The identification of this toxicity is challenging because of its rarity and possible underlying psychiatric comorbidities. Herein we describe the case of a schizophrenic 56-year-old male admitted to the Emergency Department for abdominal pain and diarrhea resulted in a rare case of acute toxicity by Salvia officinalis.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 3","pages":"429-433"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10832869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139682177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
José Ricardo Vanzin, Artur Eduardo Martio, Moema Nene Santos, Nerio Dutra Azambuja, Octávio Ruschel Karam, Luciano Bambini Manzato
{"title":"Hydrocephalus Resolution with Third Ventriculostomy with Floor Stenting: Technical Note and Literature Review.","authors":"José Ricardo Vanzin, Artur Eduardo Martio, Moema Nene Santos, Nerio Dutra Azambuja, Octávio Ruschel Karam, Luciano Bambini Manzato","doi":"10.12865/CHSJ.49.03.19","DOIUrl":"10.12865/CHSJ.49.03.19","url":null,"abstract":"<p><strong>Introduction: </strong>The management of refractory obstructive hydrocephalus is a paramount neurosurgical challenge. The endoscopic third ventriculostomy (ETV) has been accepted as the procedure of choice for obstructive hydrocephalus, depending on the presence of certain risk factors, such as intracranial infections, young age, previous shunt failure and distorted anatomy of the ventricular floor, that predispose occlusion or obstruction of the CSF outflow through the stoma.</p><p><strong>Case report: </strong>A 20-year-old man with obstructive hydrocephalus due to primary aqueductal stenosis performed several neurosurgical procedures, including two previous ETV, without long term resolution. We performed another ETV, with stent placement at the stoma to prevent occlusion. After 25 months of asymptomatic follow-up, the patient presented with an enlarged fourth ventricle, and a new neuroendoscopic procedure showed a patent stoma and a well-placed stent.</p><p><strong>Discussion: </strong>Stent placement on the third ventricular floor was already reported 19 times in the literature. Its success rate is about 94,7%, and complications happened in 2 cases, with functional impaired in only one of them.</p><p><strong>Conclusion: </strong>Third ventriculostomy with floor stenting proved to be an effective procedure in our case of complex hydrocephalus. It is a viable option in cases where there is a greater chance of stoma occlusion.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 3","pages":"438-444"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10832873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139682183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Genomic Profiling - A Need for Clinical Decision? -Case Reports.","authors":"Ana-Maria Ciurea, Michael Schenker, Cristina Mihaela Ciofiac, Liliana Streba, Ramona Schenker, Costin Teodor Streba","doi":"10.12865/CHSJ.49.03.22","DOIUrl":"10.12865/CHSJ.49.03.22","url":null,"abstract":"<p><p>Cancer is still an important health issue worldwide due to increased incidence and mortality. Personalized medicine is the future of cancer treatment. Development in technology improved technical skills in DNA/RNA sequencing. NGS technology in solid-tumor samples can describe DNA or RNA analysis by including the entire genome to detect clinical relevant mutations. Genetic results may be considered having a dynamic impact because of heterogenous molecular alterations depending of time and treatment influence. We conducted a retrospective study of all NGS tests made in the last five years for the patients from 'Sf. Nectarie' Oncology Center, Craiova, Romania. We selected three relevant clinical cases where NGS analysis was performed and the results changed the perspective of the clinical decision. Our aim is to evaluate the importance of NGS results in clinical approach. Although medicine known an important development during the last decades, only a few patients can benefit of advanced personalized treatments. It is still hard to identify the alterations or gene mutations because of genetic tests are not easily available and only a small proportion of patients carries genetic alterations.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 3","pages":"467-473"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10832885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139682182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Andrei Biţă, Ion Romulus Scorei, Tudor Adrian Bălşeanu, Gabriela Rău, Maria Viorica Ciocîlteu, George Dan Mogoşanu
{"title":"Zinc-Boron Complex-Based Dietary Supplements for Longevity and Healthy Life.","authors":"Andrei Biţă, Ion Romulus Scorei, Tudor Adrian Bălşeanu, Gabriela Rău, Maria Viorica Ciocîlteu, George Dan Mogoşanu","doi":"10.12865/CHSJ.49.03.10","DOIUrl":"10.12865/CHSJ.49.03.10","url":null,"abstract":"<p><p>The nutritional role of zinc (Zn) and boron (B) in the plant-animal-human food chain is highly topical worldwide research. Our data indicated that Zn-B complex (ZBC)-based dietary supplements can be used as stable non-toxic formulations, with high intestinal absorption rate, inducing alpha2-macroglobulin (A2M) expression for longevity and healthy life. ZBC is metabolized by hydrolysis, mainly at the absorption site (intestinal level), and most of it is excreted in the urine. Within seven hours from the administration in mice, almost the entire amount of orally absorbed ZBC is eliminated in a metabolized form. The highest amount of A2M protein in mouse liver was determined by immunoabsorbance assay in the chronic experiment (1000mg/kg of ZBC), followed by the subchronic experiment (at the same dose of ZBC), and by the acute experiment (5000mg/kg of ZBC).</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 3","pages":"381-387"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10832868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139682160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Radu-Florin Fruntealată, Tudor Adrian Balseanu, Oliviu Nica, Alina Andreea Negrila, Ilaria Lorena Petrovici, Elena Alexandra Marinescu, George-Alin Stoica, Maria Stoica, Ana-Maria Ciurea, Marius-Eugen Ciurea
{"title":"Retrospective Study of a Patient with Multiple de Novo Skin Tumor Formations.","authors":"Radu-Florin Fruntealată, Tudor Adrian Balseanu, Oliviu Nica, Alina Andreea Negrila, Ilaria Lorena Petrovici, Elena Alexandra Marinescu, George-Alin Stoica, Maria Stoica, Ana-Maria Ciurea, Marius-Eugen Ciurea","doi":"10.12865/CHSJ.49.03.18","DOIUrl":"10.12865/CHSJ.49.03.18","url":null,"abstract":"<p><p>In Romania, the incidence of malignant melanocytic tumors is continuously increasing. According to the World Health Organization, the incidence of melanocytic and non-melanocytic skin neoplasms has increased considerably and globally, in the last decade. We present the case of a 49-year-old patient who, over the course of 7 years, came in the Plastic Surgery Clinic of the Emergency County Hospital of Craiova for the excision of a number of 25 skin tumor formations, located on the face, cervical region, trunk and upper limbs. Treatment included complete microsurgical excision and supervision. In the end, the patient's treatment compliance decreased significantly.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 3","pages":"434-437"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10832871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139682158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alexandra Florinda Ghițan, Victor Gheorman, Ion Udriștoiu, Marius Eugen Ciurea
{"title":"Considerations on Patients' Quality of Life Following Hand and Forearm Trauma in the Oltenia Region.","authors":"Alexandra Florinda Ghițan, Victor Gheorman, Ion Udriștoiu, Marius Eugen Ciurea","doi":"10.12865/CHSJ.49.02.273","DOIUrl":"10.12865/CHSJ.49.02.273","url":null,"abstract":"<p><p>Hand and forearm trauma is a significant public health concern that has notable physical, psychological, and socioeconomic implications. Understanding the variations in occurrence and characteristics of injuries across different regions is crucial for effective implementation of preventive measures, management strategies, and resource allocation. The study involved 86 cases, with a range of ages from 18 to 70 years old. The participant group consisted of 11 females and 75 males. A series of clinical parameters were analyzed, including gender, age, environment, and cause of trauma. The study requested that participants provide information regarding if they reintegrated into their professional lives and complete the WHOQOL-BREF assessment, which is a tool used to evaluate quality of life. The current investigation has determined that the primary etiologies for hand and forearm injuries are crush and sharp cuts. The results of the investigation indicate a noteworthy association among Age and Cause, Gender and Age, Age and Professional reintegration, as well as between WHOQOL-BREF scores and different parameters. The procurement of epidemiological data plays a crucial role in broadening our comprehension of acute hand and forearm injuries in the Oltenia region.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 2","pages":"273-279"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/37/59/CHSJ-49-02-273.PMC10541057.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41124441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ianis Kevyn Stefan Boboc, Alina Catalina Chirea, Victor Gheorman, Andrei Gresita, Tudor-Adrian Balseanu, Bogdan Catalin, Daniela Calina
{"title":"Investigating the Neuroprotective and Neuroregenerative Effect of Trazodone Regarding Behavioral Recovery in a BL6C57 Mice Stroke Model.","authors":"Ianis Kevyn Stefan Boboc, Alina Catalina Chirea, Victor Gheorman, Andrei Gresita, Tudor-Adrian Balseanu, Bogdan Catalin, Daniela Calina","doi":"10.12865/CHSJ.49.02.210","DOIUrl":"10.12865/CHSJ.49.02.210","url":null,"abstract":"<p><p>Stroke is a major cause of death and disability worldwide. Between 1990 and 2010, its global burden increased notably with reference to the absolute number of incident events, number of deaths, and disability-adjusted life-years lost. Trazodone is a triazolopyridine derivative that was approved for more than 40 years as monotherapy or in combination with other antidepressant drugs for the treatment of major depressive disorder in adult patients. The aim was investigated if trazodone can improve behavioural outcome after stroke in a mice model of middle cerebral artery occlusion (MCAo) due to the potential neuroprotective and neurodegenerative effects by using three behavioural tests: adhesive tape test, beam test and hole board test. Trazodone administration show modest improvements regarding the motor-sensorial function after stroke especially in the acute post-stroke phase in aged and young animals. The antidepressant effect of the drug was observed in the post-stroke period in aged animals and to a lesser extent in young animals. Future research is needed to evaluate the effects of trazodone at the cellular level to be sure that it has no benefit in stroke patients who do not suffer from depression.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 2","pages":"210-219"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d8/c0/CHSJ-49-02-210.PMC10541511.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41159870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dorin Nicolae Gheorghe, Dora Maria Popescu, Stefan Cristian Dinescu, Mihail Virgil Boldeanu, Petra Surlin, Florentin Vreju, Paulina Lucia Ciurea
{"title":"Clinical Evaluation of Periodontal Status and IL-6 Gingival Fluid Level in Patients with Sjogren's Syndrome.","authors":"Dorin Nicolae Gheorghe, Dora Maria Popescu, Stefan Cristian Dinescu, Mihail Virgil Boldeanu, Petra Surlin, Florentin Vreju, Paulina Lucia Ciurea","doi":"10.12865/CHSJ.49.02.163","DOIUrl":"10.12865/CHSJ.49.02.163","url":null,"abstract":"<p><p>The objective of the cross-sectional study was to assess periodontal and implant health condition among individuals diagnosed with Sjogren's Syndrome (SS), taking into account the clinical circumstances associated with this patient population. The clinical parameters employed to evaluate the periodontal status of both natural teeth and implants included: periodontal probing depth (PPD) measured at six sites per tooth/implant, clinical attachment level (CAL), bleeding on probing index (BOP), plaque index (PLQ). Gingival crevicular fluid samples were collected for interleukin-16 level evaluation. After clinical and immunological assessment of the study and control groups, the data was centralized, compiled and submitted for statistical analysis. In all four types of assessed periodontal parameters, there were statistically significant differences between the SS patients with no dental implants and the other test (SSi) and control groups (Cni and Ci). Nevertheless, in SS patients with dental implants, plaque levels were similar to that of controls. In addition, other periodontal parameters (PPD, BOP and CAL) were similar in SS patients with dental implants and controls, with no statistically significant difference. The highest GCF IL-6 levels were found in SS patients with no dental implants, the differences to the other study and control groups being statistically significant. In patients with SS and dental implants, there were no statistically significant differences to the other groups. Individuals diagnosed with Sjogren's Syndrome (SS) exhibit a less favorable periodontal condition compared to controls without SS. Notably, SS patients who undergo dental implant procedures demonstrate an improvement in their periodontal status. This highlights the importance of proactive and ongoing dental and periodontal surveillance for SS patients, aiming to decrease the risk of developing periodontal diseases.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 2","pages":"163-171"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/c2/CHSJ-49-02-163.PMC10541508.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41162610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Prevalent Cases of Endometrial Carcinoma in Different Life Periods of Women-Clinical and Histopathological Diagnosis.","authors":"Hajrullah Latifi, Astrit M Gashi, Drilon Latifi","doi":"10.12865/CHSJ.49.02.151","DOIUrl":"10.12865/CHSJ.49.02.151","url":null,"abstract":"<p><p>Abnormal uterine bleeding is a term used to describe any irregular bleeding from the uterus that is not part of a woman's normal menstrual cycle and can happen during different life periods. Abnormal uterine bleeding can have structural etiologies (polyp, adenomyosis, leiomyoma, malignancy) or nonstructural etiologies (coagulopathy, ovulatory dysfunction, and not-classified). The post- and pre-menopausal period requires a detailed investigation to establish the etiology of the bleeding because the chances that the woman has a malignancy are plentiful in this period. The treatment plan is determined based on the underlying cause of the bleeding. The main objective of this paper was to determine the prevalence of endometrial carcinoma in different periods, focusing on the postmenopausal period. This research was a cross-sectional study and included 79 cases of abnormal uterine bleeding in different periods of women's lives. Our study found that abnormal uterine bleeding occurs more frequently during the premenopausal period (59%) and that the causes of irregular bleeding during this period were mainly benign. Our study focused on the postmenopausal period, where we found that 32.9% of irregular uterine bleeding occurs during this period, and the leading causes were malignant pathologies (83.3%), mainly endometrial adenocarcinomas. The average age was 66.7 years. During the study, it was observed that 50% of women with abnormal uterine bleeding due to malignancy were classified as overweight, 25% were obese, and 25% had normal weight. It was confirmed that obesity is a co-factor of malignancy in the postmenopausal period, and the pathophysiological mechanism is well understood now. Our study also found a high number of co-morbidities among women with abnormal uterine bleeding due to malignancy. We came to the conclusion that any abnormal uterine bleeding should be initially investigated in a multidisciplinary manner, an accurate diagnosis should be determined, and then a treatment plan should be established. The treatment strategy should be determined depending on the cause of abnormal bleeding.</p>","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 2","pages":"151-155"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/df/CHSJ-49-02-151.PMC10541062.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41171470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}